A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy

Angeliki Asimaki, Harikrishna Tandri, Hayden Huang, Marc K Halushka, Shiva Gautam, Cristina Basso, Gaetano Thiene, Adalena Tsatsopoulou, Nikos Protonotarios, Williarn J. McKenna, Hugh Calkins, Jeffrey E. Saffitz

Research output: Contribution to journalArticle

Abstract

The diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC) can be challenging because the clinical presentation is highly variable and genetic penetrance is often low. METHODS To determine whether a change in the distribution of desmosomal proteins can be used as a sensitive and specific diagnostic test for ARVC, we performed immuno-histochemical analysis of human myocardial samples. We first tested myocardium from 11 subjects with ARVC; of these samples, 8 had desmosomal gene mutations. We also tested myocardium obtained at autopsy from 10 subjects with no clinical or pathological evidence of heart disease as control samples. All ARVC samples but no control samples showed a marked reduction in immunoreactive signal levels for plakoglobin (also known as γ-catenin), a protein that links adhesion molecules at the intercalated disk to the cytoskeleton. Other desmosomal proteins showed variable changes, but signal levels for the nondesmo-somal adhesion molecule N-cadherin were normal in all subjects with ARVC. To determine whether a diminished plakoglobin signal level was specific for ARVC, we analyzed myocardium from 15 subjects with hypertrophic, dilated, or ischemic cardiomyopathies. In every sample, levels of N-cadherin and plakoglobin signals at junctions were indistinguishable from those in control samples. Finally, we performed blinded immunohistochemical analysis of heart-biopsy samples from the Johns Hopkins ARVC registry. We made the correct diagnosis in 10 of 11 subjects with definite ARVC on the basis of clinical criteria and correctly ruled out ARVC in 10 of 11 subjects without ARVC, for a sensitivity of 91%, a specificity of 82%, a positive predictive value of 83%, and a negative predictive value of 90%. The plakoglobin signal level was reduced diffusely in ARVC samples, including those obtained in the left ventricle and the interventricular septum. CONCLUSIONS Routine immunohistochemical analysis of a conventional endomyocardial-biopsy sample appears to be a highly sensitive and specific diagnostic test for ARVC.

Original languageEnglish (US)
Pages (from-to)1075-1084
Number of pages10
JournalNew England Journal of Medicine
Volume360
Issue number11
DOIs
StatePublished - Mar 12 2009

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Asimaki, A., Tandri, H., Huang, H., Halushka, M. K., Gautam, S., Basso, C., Thiene, G., Tsatsopoulou, A., Protonotarios, N., McKenna, W. J., Calkins, H., & Saffitz, J. E. (2009). A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. New England Journal of Medicine, 360(11), 1075-1084. https://doi.org/10.1056/NEJMoa0808138